Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedX Health
Mississauga or Toronto area, Ontario, Canadamedxhealth.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
MedX Health’s SIAscopy on DermSecure platform enables rapid non-invasive imaging of skin lesions for remote dermatologist assessment. The system has processed over 200,000 scans globally and supports early detection of melanoma with a proven catch rate of ~11% suspicious moles identified within 72 hours. The company’s products are FDA and CE approved and commercially available in multiple markets including Canada, the US, EU, Australia
- Therapeutic areas
- OncologyDermatologyNeurology
- Modalities
- Device
- Industry
- Medical Imaging
02
Partnerships
Vitamed Biomedical (Italy)Medispa (Italy) – for teledermatology expansion in Italy
Beyond the preview
Go deeper on MedX Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MedX Health.